Navigation Links
Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
Date:12/7/2009

NEW ORLEANS, Dec. 7 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterized by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The data were presented as an oral presentation at the 2009 American Society of Hematology (ASH) Annual Meeting and Exposition (ASH Abstract #680). Additionally, updated five-year follow-up results from an ongoing, open-label extension study in adults were presented and add to the data available on the long-term efficacy and safety of Nplate in adult patients with chronic ITP (ASH Abstract #681).

Results from Phase 1/2 Study in Children (Abstract #680)

ITP in children most commonly presents as an acute illness; however, 20-30 percent of these cases will persist as chronic ITP (duration over six months). Results of the study showed that treatment with Nplate appeared to be generally well-tolerated compared to placebo in children (aged 12 months to less than 18 years old) with chronic ITP (treatment related adverse events = 18 percent vs. 20 percent, respectively).

"Currently, most drug treatment options for children with chronic ITP involve immunosuppression," said Dr. George R. Buchanan, professor of Pediatrics at the University of Texas Southwestern Medical Center at Dallas. "This is the first study of an agent that stimulates platelet production in the pediatric population. The results suggest that Nplate could potentially be an important treatment option for selected children suffering from chronic ITP."

Safety results of the study showed that adverse event rates were similar between
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
2. New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
3. Amgen Highlights Data to be Presented at ASH
4. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
5. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
6. Call for Applications: The Amgen Award for Science Teaching Excellence
7. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
10. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
11. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CITY , June 18, 2013 ... products for healthcare and life sciences research, today ... Services Administration (GSA) IT Schedule 70 supply contract ... certified to provide innovative IT solutions to government ... accordance with this contract, Remedy has placed its ...
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013 Valeant Pharmaceuticals International, ... today that it has filed a preliminary prospectus supplement to ... today made a similar filing with securities regulatory authorities in ... in connection with a public offering of its common shares ... The Company will also grant to the underwriters ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
...  GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 2011 on Thursday, March 15, 2012, before the U.S. financial ... and conference call at 10:00 a.m. EDT to discuss the ... outlook. To listen to the live conference ...
... release of System 7 – the next generation of heavy ... such as hip and knee replacements. System 7 offers the ... and highest performing power tool system ever from Stryker. ... heavy duty power tools in 1982, and has built a ...
Cached Medicine Technology:GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 2Stryker Launches Next Generation Heavy Duty Surgical Power Tools 2
(Date:6/18/2013)... June 19, 2013 The Drug Delivery ... unprecedented access to the drug delivery partnering deals and ... , The report provides a detailed understanding and ... partnering deals. The majority of deals are discovery or ... an option right to license the license drug delivery ...
(Date:6/18/2013)... Alto, CA (PRWEB) June 18, 2013 Palo ... be one of America's greenest cities with its recent major ... Council authorized three major solar electric power purchase agreements ... to 182,500 megawatt-hours (MWh) of solar photovoltaic electric power per ... the City’s electric needs. That’s enough power to supply ...
(Date:6/18/2013)... research has shown that cancer cells have a much ... cells. Now, scientists at The University of Texas at ... a new strategy to combat lung cancer. , In ... PLOS ONE , UT Dallas researchers compared the ... lung cells taken from the same patient. , ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... June 18, 2013 A new $119 ... The burgeoning aquaculture industry is redefining the way consumers ... the most acclaimed personal culinary chefs on the Emerald ... benefits of sustainable seafood and the promising industry of ... these days. Many consumers strive to fully partake in ...
Breaking Medicine News(10 mins):Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... has a love-hate relationship with iron. Just the right amount is ... brain diseases like Alzheimer,s and Parkinson,s. Science knows ... women. These higher levels may be part of the explanation for ... But why do women have less iron in ...
... to perform everyday activities. This is not primarily due to ... was previously believed new research from the University of ... initiate and complete a task towards a specific goal. ... normally results in a degree of paralysis in the lower ...
... will discuss scientific studies of mutual interests and explore ... Oct. 24-26. The Ohio State University Medical Center is ... first of its kind between the two countries. , ... countries are expected to speak at the event that ...
... providers assess blood and tissue type as well as ... research indicates that checklist might also need to include ... shown the time of day transplant surgery is performed ... dysfunctional internal clocks is the first correlating circadian clocks ...
... 4 (HealthDay News) -- Readmission rates have increased in ... the country,s most elite academic medical centers, new research ... to the hospital within 30 days of being discharged ... as hospitals brace for penalties -- reduced payments for ...
... shows that exposure to stressors in the Neonatal Intensive ... brain structure and function of very preterm infants. According ... Neurology , a journal published by Wiley-Blackwell on behalf ... infants who experienced early exposure to stress displayed decreased ...
Cached Medicine News:Health News:Hysterectomy is associated with increased levels of iron in the brain 2Health News:Hysterectomy is associated with increased levels of iron in the brain 3Health News:Children with spina bifida need personal 'starter' 2Health News:Ohio State organizes research sharing between Brazil, US 2Health News:Circadian clock may impact organ transplant success 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 3Health News:Preterm infants exposed to stressors in NICU display reduced brain size 2
Inquire...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
20L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: